1 January 2024 false Taxfiler 2024.6 true 11023249business:PrivateLimitedCompanyLtd2024-01-012024-12-31 110232492023-12-31 110232492024-01-012024-12-31 11023249business:AuditExempt-NoAccountantsReport2024-01-012024-12-31 11023249business:FilletedAccounts2024-01-012024-12-31 110232492024-12-31 11023249business:Director12024-01-012024-12-31 11023249business:CompanySecretary12024-01-012024-12-31 11023249business:RegisteredOffice2024-01-012024-12-31 110232492023-12-31 11023249core:WithinOneYear2024-12-31 11023249core:WithinOneYear2023-12-31 11023249core:AfterOneYear2024-12-31 11023249core:AfterOneYear2023-12-31 11023249core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 11023249core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 11023249core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 11023249core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 11023249core:PreviouslyStatedAmount2024-12-31 11023249core:PreviouslyStatedAmount2023-12-31 11023249business:SmallEntities2024-01-012024-12-31 11023249countries:EnglandWales2024-01-012024-12-31 11023249core:Goodwill2023-12-31 11023249core:Goodwill2024-12-31 11023249core:Goodwill2024-01-012024-12-31 11023249business:OrdinaryShareClass12024-01-012024-12-31 11023249business:OrdinaryShareClass12023-01-012023-12-31 110232492023-01-012023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 11023249 (England and Wales)
Ellipse Medical Limited Unaudited accounts for the year ended 31 December 2024
Ellipse Medical Limited Unaudited accounts Contents
Page
- 2 -
Ellipse Medical Limited Company Information for the year ended 31 December 2024
Director
R. Blood
Secretary
S Kendrick
Company Number
11023249 (England and Wales)
Registered Office
114 Power Road Unit 3.1 London W4 5PY
- 3 -
Ellipse Medical Limited Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
- 
102,225 
Current assets
Debtors
- 
339,019 
Cash at bank and in hand
115,426 
144,192 
115,426 
483,211 
Creditors: amounts falling due within one year
(7,076)
(37,102)
Net current assets
108,350 
446,109 
Total assets less current liabilities
108,350 
548,334 
Creditors: amounts falling due after more than one year
(689,436)
(1,025,744)
Net liabilities
(581,086)
(477,410)
Capital and reserves
Called up share capital
50,000 
50,000 
Profit and loss account
(631,086)
(527,410)
Shareholders' funds
(581,086)
(477,410)
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 16 March 2025 and were signed on its behalf by
R. Blood Director Company Registration No. 11023249
- 4 -
Ellipse Medical Limited Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Ellipse Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 11023249. The registered office is 114 Power Road, Unit 3.1, London, W4 5PY.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Going concern
These accounts have been prepared on the going concern basis. There was a net deficiency of assets of £658,082 at the balance sheet date, however the parent company has confirmed continued support to ensure the company retains sufficient working capital to continue trading for the foreseeable future.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 January 2024
780,626 
At 31 December 2024
780,626 
Amortisation
At 1 January 2024
678,401 
Charge for the year
102,225 
At 31 December 2024
780,626 
Net book value
At 31 December 2024
- 
At 31 December 2023
102,225 
- 5 -
Ellipse Medical Limited Notes to the Accounts for the year ended 31 December 2024
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
- 
7,564 
Amounts due from group undertakings etc.
- 
331,455 
- 
339,019 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Trade creditors
4,776 
4,776 
Taxes and social security
- 
30,976 
Accruals
2,300 
1,350 
7,076 
37,102 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Amounts owed to group undertakings and other participating interests
437,936 
774,244 
Other creditors
251,500 
251,500 
689,436 
1,025,744 
8
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
50,000 Ordinary shares of £1 each
50,000 
50,000 
9
Controlling party
The ultimate holding company is Syneron Medical Ltd, a company registered in Israel.
10
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 6 -